Constellation Capital Corp. is a Canada-based capital pool company. The principal business of the Company is to identify and evaluate assets or businesses with a view to acquire them or an interest therein by completing a purchase transaction.

Employees

Sector

Investment Holding Companies

More about the company

Income Statement and Estimates

More financial data

Market Closed - Toronto S.E. Other stock markets 19:00:00 21/01/2026 +03			5-day change	1st Jan Change
0.0700 ^CAD	-.--%		-.--%	-

07-28	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	476K 339K 295K 275K 252K 32.39M 483K 3.24M 1.27M 16.13M 1.27M 1.25M 54.07M	P/E 2024	-7.49x	P/E 2025	-8.26x
Enterprise Value	-150K -107K -93.1K -86.65K -79.56K -10.22M -153K -1.02M -401K -5.09M -402K -393K -17.07M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	90.67%	Yield 2024 *	-	Yield 2025	-

07-28	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-09	Active Witness Corp. entered into letter of intent to acquire Constellation Capital Corp. (TSXV:CNST.P) in a reverse merger transaction for CAD 16.4 million.	CI
01-30	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-11	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
15/07/25	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
24/04/25	Constellation Capital Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
23/01/25	Constellation Capital Corp. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/01/25	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
17/01/25	300,000 Stock Options of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2025.	CI
30/10/24	Constellation Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
22/07/24	Constellation Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
20/07/24	1,300,000 Common Shares of Constellation Capital Corp. are subject to a Lock-Up Agreement Ending on 20-JUL-2024.	CI

04-02	Constellation Announces Extension to Amalgamation Agreement with Active Witness Corp.	AQ
02-09	Constellation Announces Proposed Acquisition of Active Witness Corp.	AQ
11-14	Constellation Announces Extension Of LOI For The Proposed Acquisition Of Active Witness Corp.	AQ
29/09/25	Constellation Announces Proposed Acquisition Of Active Witness Corp.	AQ
29/09/25	Canadian Investment Regulatory Organization Trading Halt - CNST.P	AQ

Constellation Capital Corp. Stock

Stocks

CNST.P

CA21036W1032

Investment Holding Companies

Valuation: Constellation Capital Corp.

Chart: Constellation Capital Corp.

Latest news : Constellation Capital Corp.

Press Releases: Constellation Capital Corp.

Course Extremes

Managers and Directors: Constellation Capital Corp.

Latest insider transactions

Shell Companies

Financials

Company Profile

Income Statement and Estimates

1 year	0.04	0.15
3 years	0.04	0.15
5 years	0.04	0.15
10 years	0.04	0.15

Director	Title	Age	Since
Dayton Marks BRD	Director/Board Member	33	27/07/2022
Roger Jewett BRD	Director/Board Member	63	01/01/2022
Robert Quinn BRD	Director/Board Member	70	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
12/10/24 A	Roger Jewett	Buy	Director	10,000	0.1471%
12/5/24 A	Roger Jewett	Buy	Director	50,000	0.7353%
12/5/24 A	Roger Jewett	Buy	Director	60,000	0.8824%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONSTELLATION CAPITAL CORP.	-.--%	-.--%	+100.00%	-22.22%	339K
BOXABL INC.	-1.93%	-6.72%	-53.83%	-	13.74B
FREENOME, INC.	+11.61%	-0.80%	+5.49%	-	1.26B
CHURCHILL CAPITAL CORP XI	-1.00%	+1.32%	-	-	772M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	+0.10%	-	-	644M
CENTIEL AG	-.--%	-6.95%	+268.42%	-68.57%	621M
CHURCHILL CAPITAL CORP XII	+0.24%	-2.30%	-	-	607M
BAIN CAPITAL GSS INVESTMENT CORP.	-.--%	-0.05%	-	-	597M
CANTOR EQUITY PARTNERS IV, INC.	-.--%	-0.86%	-	-	595M
Average	+0.98%	+0.61%	+80.02%	-45.40%	2.09B
Weighted average by Cap.	-0.67%	+11.44%	-36.23%	-68.55%

	2024	2025
Net sales	-	-
Net income	-45.38K -32.35K -28.12K -26.17K -24.03K -3.09M -46.08K -309K -121K -1.54M -121K -119K -5.15M	-57.62K -41.07K -35.7K -33.23K -30.51K -3.92M -58.51K -392K -154K -1.95M -154K -151K -6.55M
Net Debt	-679K -484K -421K -392K -359K -46.19M -689K -4.62M -1.81M -23M -1.82M -1.78M -77.11M	-626K -446K -388K -361K -332K -42.61M -636K -4.26M -1.67M -21.21M -1.68M -1.64M -71.14M